Gaines Kristin Sallee 4
4 · NATIONAL HEALTH INVESTORS INC · Filed Sep 26, 2024
Insider Transaction Report
Form 4
Gaines Kristin Sallee
SVP/Chief Transaction Officer
Transactions
- Tax Payment
Common Stock
2024-09-25$84.66/sh−48,665$4,119,979→ 57,944 total - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2024-09-25−18,333→ 0 totalExercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2024-09-25−18,333→ 0 totalExercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - Exercise/Conversion
Common Stock
2024-09-25$69.20/sh+18,333$1,268,644→ 69,942 total - Exercise/Conversion
Common Stock
2024-09-25$69.20/sh+18,334$1,268,713→ 106,609 total - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2024-09-25−18,334→ 0 totalExercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (18,334 underlying) - Exercise/Conversion
Common Stock
2024-09-25$69.20/sh+18,333$1,268,644→ 88,275 total
Holdings
- 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2021-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 18,334
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (18,334 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,334 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2020-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2022-02-21Exp: 2025-02-21→ Common Stock (18,334 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,334 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying)
Footnotes (1)
- [F1]Acquired due to the net exercise of stock options granted 2/25/21 with shares withheld by the Company to cover the exercise price and taxes. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.